chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 59 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 30Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "IBS" (unspecified if ongoing), notes: other medical history: IBS. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: patient received Paxlovid as COVID 19 Treatment.  Treatment start date: 24Jun2023, treatment stop date: 26Jun2023 lot number: GG5318   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Nov2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 43 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ATENOLOL, start date: 01May2022, stop date: 16Jul2023. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2023, outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received Paxlovid treatment from 07Jul2023 to 12Jul2023 for COVID-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300252538 Same patient, different drug/ AE;
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 as dose 5 (booster), single (Lot number: GH9693) at the age of 69 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3, single (Batch/Lot number: unknown) and as dose 4, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 22Jun2023, outcome "recovering" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.with Paxlovid from 24Jun2023 to  28Jun2023.  Clinical Course: The patient had no known allergies. The other medications received in 2 weeks of Paxlovid are: Tamulosin, Atenolol and Hydrochlorothiozide.
Sex: U
Vaccine: PNC13
Symptoms: Device issue
Clinical narrative: Upon putting a needle on a Prevnar prefilled syringe, the hub snapped off.; The initial case was missing the following minimum criteria: Other-Info not qualifying for AE reporting - unspecified product. Upon receipt of follow-up information on (06Jul2023), this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) from product quality group.  A patient (no qualifiers provided) received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Lot number: GF1990, Expiration Date: 30Apr2025) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEVICE ISSUE (non-serious), outcome "unknown", described as "Upon putting a needle on a Prevnar prefilled syringe, the hub snapped off.".  Additional information: Sample availability was unknown, photos were available.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fear of death
Clinical narrative: fear of death; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), on 05Feb2021 as dose 1, single (Lot number: EN9581) at the age of 74 years for covid-19 immunisation. The patient's relevant medical history included: "accident" (unspecified if ongoing), notes: I have had a serious accident. The patient's concomitant medications were not reported. The following information was reported: FEAR OF DEATH (non-serious) with onset 2021, outcome "unknown".  Additional Information: It was reported that the patient was vegan and practiced yoga for 50 plus year doing fine even though she had a serious accident. She overcame all of that and reported that 3 shots took all of that away. She reported that it was never listed that the  underline diseases or effects of covid shots caused her fear of death and job loss and reported that she accepted the poison.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300146105 same reporter/patient/product, different dose/event;US-PFIZER INC-PV202300123303 same reporter/patient/product, different dose/event;
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fear of death
Clinical narrative: fear of death; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient received BNT162b2 (BNT162B2), on 27Feb2021 as dose 2, single (Lot number: EN6202) at the age of 74 years for covid-19 immunisation. The patient's relevant medical history included: "I have had a serious accident" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot number: EN9581), administration date: 05Feb2021, when the patient was 74-year-old, for Covid-19 immunization, reaction(s): "Fear of death". The following information was reported: FEAR OF DEATH (non-serious) with onset 2021, outcome "unknown".  Additional Information: It was reported that the patient was vegan and practiced yoga for 50 plus year doing fine even though she had a serious accident. She overcame all of that and reported that 3 shots took all of that away. She reported that it was never listed that the  underline diseases or effects of covid shots caused her fear of death and job loss and reported that she accepted the poison.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300146105 Same patient, different dose/event;US-PFIZER INC-PV202300123302 same reporter/patient/product, different dose/event;
Sex: U
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Pulmonary embolisms in both lungs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: JUICE PLUS (ongoing). The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "Pulmonary embolisms in both lungs". Clinical course: Patient had been on Juice Plus 20 years that's how patient found out that had a heart, lungs and blood pressure of a kid.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: she's having a hard time hearing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (RA). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Booster (2nd), DOSE 4), administration date: Nov2022, for COVID-19 immunization; Bnt162b2 (Booster (1st), DOSE 3), administration date: Aug2022, for COVID-19 immunization; Bnt162b2 (Dose 1), for COVID-19 immunization; Bnt162b2 (Dose 2), for COVID-19 immunization. The following information was reported: HYPOACUSIS (non-serious), outcome "unknown", described as "she's having a hard time hearing".  Additional information: Patient had all the Pfizer vaccinations and boosters in 2022. She would like to know if she needs to take the new booster. She had no side effects with the vaccines. Caller mentioned that she started to take Pfizer vaccines because she is up in years and she's healthy. She has no lasting effects at all from Pfizer vaccines. They are wonderful and happy to take them. She also had 2 boosters in November and Aug2022. She said that they are telling people to go for a 3rd vaccine booster because more stuff was added for the diseases. She is wondering if she needs to go for a new 4th booster. She has not had any booster since 2022. She had one in February. She mentioned that she is worried because half of 2023 has gone and she needs to know if boosters are ready.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300251590 same patient, different vaccine dose/event;
Age: 4.0
Sex: U
Vaccine: DTAP
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: administration of daptacel past the expiration date with no reported adverse event; Initial information received on 12-Jul-2023 regarding an unsolicited valid non-serious case received from a physician.  This case is linked to cases 2023SA213495, 2023SA213561, 2023SA214713, 2023SA213484, 2023SA214480 and 2023SA214127.  This case involves 4 years old and unknown gender patient who had administration of diphtheria-15/tetanus/5 AC pertussis vaccine [Daptacel] past the expiration date with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included polio vaccine inact 3V (VERO) (IPOL [polio vaccine inact 3v (vero)]) for immunisation; measles vaccine, mumps vaccine, rubella vaccine (MMR) for immunisation; and varicella zoster vaccine live (OKA/MERCK) (Varivax [varicella zoster vaccine live (OKA/MERCK)]) for Immunisation.  On 07-Jun-2023, the patient received a standard dose 5 of suspect diphtheria-15/tetanus/5 AC pertussis vaccine Suspension for injection at a dose of 0.5 mL (lot C5829AA; Expiry date: 03-Jan-2023) via intramuscular route in unknown administration site for Immunization, past the expiration date with no reported adverse event (expired product administered) (same day latency). Caller is looking for re-vaccination information  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: TD
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: administration of an expired product to a patient with no reported adverse event; Initial information was received on 14-Jul-2023 regarding an unsolicited valid non-serious case received from an other health professional (Pharmacist).  This case involves an unknown age patient of unknown gender who received an expired product of diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event   The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of an expired suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection (lot number: U7092AA, expiration date: 24-Jun-2023, strength, route, administration site: Unknown) for Immunization (immunisation) with no reported adverse event (expired product administered) (latency: same day).  It was reported that "The product displayed an expiration date of 24-Jun-23. The caller believed that this meant that the vaccine expired 23-Jun-2024. It was administered to a patient. After speaking with the pharmacy technician, the pharmacist came on the line. She explained their confusion in reading the expiration date."  No lab data reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event administration of an expired product to a patient with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 5.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: patient received an expired dose of quadracel today with no reported adverse event; Initial information was received on 14-Jul-2023 regarding an unsolicited valid non-serious case received from a consumer/non-health-care professional.  This case involves 5 years old female patient who received an expired dose of diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine [Quadracel] today with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 14-Jul-2023, the patient received a dose of 0.5 ml of suspect diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine (Suspension for injection) lot C591AA (strength, expiry date unknown) via intramuscular route in the left thigh for Immunization.  On 14-Jul-2023 the patient developed a non-serious event of patient received an expired dose of quadracel today with no reported adverse event (expired product administered) (latency: same day) following the administration of diphtheria-15/tetanus/5 hybrid ac pertussis/ipv (mrc5) vaccine.  Action taken with DIPHTHERIA, TETANUS, AC PERTUSSIS and ipv VACCINE (Quadracel) was not applicable.  At time of reporting, the outcome was Unknown for the event patient received an expired dose of quadracel today with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 43.0
Sex: M
Vaccine: MNQ, YF
Symptoms: Abdominal tenderness, Cardiac function test, Chest discomfort, Oxygen saturation decreased, Pruritus
Clinical narrative: Initial exam was significant for normal vital signs, urticaria to back, neck and left forearm. Mild tenderness to palpation to LLQ. No oral edema was appreciable, pulmonary exam without wheezing, cardiac exam with RRR. Initial epi pen was administered. Patient continued to endorse worsening urticaria and itch as well as chest tightness and second dose of epinephrine was administered approximately 8 minutes later. His oxygen levels dropped to the 92-94% so supplemental O2 was initiated via a non rebreather. On transfer to EMS team, patient was in stable condition.
Age: 43.0
Sex: M
Vaccine: MNQ, YF
Symptoms: Pulmonary function test normal, Urticaria
Clinical narrative: Initial exam was significant for normal vital signs, urticaria to back, neck and left forearm. Mild tenderness to palpation to LLQ. No oral edema was appreciable, pulmonary exam without wheezing, cardiac exam with RRR. Initial epi pen was administered. Patient continued to endorse worsening urticaria and itch as well as chest tightness and second dose of epinephrine was administered approximately 8 minutes later. His oxygen levels dropped to the 92-94% so supplemental O2 was initiated via a non rebreather. On transfer to EMS team, patient was in stable condition.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 27-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023).    No concomitant medication information was provided. The vial was initially thawed on 10Jun2023. No treatment drug information was provided.   The case corresponds to 23rd out of 30 patients as reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732645 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Follow-up received, updated vaccination date and initial vial thaw date information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732645:Master case (Patient 1)
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event; We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (no adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (We gave 30 doses of Moderna bivalent vaccine after manufacturer's expiration date of 08Jun2023).    No concomitant medication information was provided. The vial was initially thawed on 10Jun2023. No treatment drug information was provided.   The case corresponds to 26th out of 30 patients as reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732645 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Follow-up significant information received, updated vaccination date and initial vial thaw date.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732645:Master case (Patient 1)
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Headache
Clinical narrative: Had second Shingrix dose July 11. Fatigue and headaches have persisted through July 17. CDC and other public information states symptoms only last 2-3 days. I'm reporting this because unless my reaction is rare, people should know that side effects can last longer than just 3 days. I had no reaction at all to the first dose. It's not a problem with Shingrix itself, I understand vaccine can have side effects. I believe the public information about the vaccine should include that side effects can persist more than 3 days and that the type of headache can require more than an otc nsaid. Here's what it took to knock down my latest headache: 3 consecutive cold packs, 3 Advil, one Excedrin migraine, and finally half a hydrocodone.
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Electrocardiogram, Electrocardiogram ambulatory, Laboratory test
Clinical narrative: chest pain, chest tightening, irregular menstruation (early and/or late)
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation irregular, Pulmonary function test, X-ray
Clinical narrative: chest pain, chest tightening, irregular menstruation (early and/or late)
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Myocardial ischaemia, Narcolepsy, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE NARCOLEPSY, UNSPECIFIED ACUTE NON ST ELEVATION MI DEMAND ISCHEMIA 1/29/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardio-respiratory arrest, Cerebrovascular accident, Death, Malaise
Clinical narrative: Presented to ED w c/o COVID-like symptoms x 2 days; admitted for COVID-19 infection; no pna; pt suffered acute stroke; pt had syncopal epsisode early morn 1/21; code blue called; unable to be resuscitated and subsequently expired.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Resuscitation, Syncope
Clinical narrative: Presented to ED w c/o COVID-like symptoms x 2 days; admitted for COVID-19 infection; no pna; pt suffered acute stroke; pt had syncopal epsisode early morn 1/21; code blue called; unable to be resuscitated and subsequently expired.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Hypoxia, Malaise
Clinical narrative: Presented to ED w/ c/o COVID-19 symptoms; cough/SOB; admitted for COVID-19 pna w/hypoxia; tx w/ steroids, abx, O2; weaned to RA; dc'd home.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Endotracheal intubation, Gastrostomy, Malnutrition, Pneumonia
Clinical narrative: Presented to ED w/pneumonia; dx as COVID-19 pna; tx w/abx; resp failure required intubation; peg placed d/t malnutrition; dc'd home w/HHC for O2 & peg tube care
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure
Clinical narrative: Presented to ED w/pneumonia; dx as COVID-19 pna; tx w/abx; resp failure required intubation; peg placed d/t malnutrition; dc'd home w/HHC for O2 & peg tube care
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Angina unstable
Clinical narrative: UNSTABLE ANGINA ACUTE NON ST ELEVATION MI
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Presented to ED from SNF w/ SOB; tested COVID-19 at SNF; admitted for COVID-19 pna w/hypoxic resp failure; tx w/O2, abx , & steroids; pt weaned to baseline O2/NC and returned to SNF.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest pain, Confusional state
Clinical narrative: Presented to ED w c/o rt sided cp & confusion; admitted for COVID-19 pna; tx w/abx, steroids; did not require O2; dc'd home
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death
Clinical narrative: Admitted for COVID-19; family did not want aggressive measures; IP hospice consulted; pt expired
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cardioversion, Condition aggravated, Hypertension, Supraventricular tachycardia
Clinical narrative: Elevated HTN that was no longer controlled be betablockers as it had been for 20 years, resulting in elevation of care. Elevation in care, adding ACE and ARB, had no effect and ultimately had development of AVNRT that required cardioversion. No previous cardiac conditions prior to vaccination.
Age: 16.0
Sex: M
Vaccine: MENB, MNQ, MENB, MNQ
Symptoms: Bradycardia, Hyperhidrosis, Syncope
Clinical narrative: Syncope. Diaphoresis. Bradycardia
Age: 16.0
Sex: M
Vaccine: MENB, MNQ, MENB, MNQ
Symptoms: Syncope
Clinical narrative: Syncope. Diaphoresis. Bradycardia
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Endotracheal intubation, Respiratory failure
Clinical narrative: Admitted for COVID-19 pna; worsening resp failure required intubation; also tx w/remdesivir, abx, steroids, zinc; pt extubated and weaned to RA; dc'd to home w/HHC
Age: 5.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMRV
Symptoms: Rash, Rash erythematous, Rash macular
Clinical narrative: Red blotchy rash over trunk and legs
Age: 42.0
Sex: M
Vaccine: HEP
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Client was given 3rd dose of Hep B vaccine, Heplisav-b, too early. First dose given 5/3/2023 (EngerixB), second dose given 6/7/2023 (Engerix B), and 3rd dose (Heplisav-b) given 7/5/2023. Third dose showing not valid as given too early, and needs to be repeated on 10/18/2023 or later. Client notified and scheduled final dose.
Age: 87.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Decreased appetite, Diarrhoea, Dyspnoea
Clinical narrative: Presented w/ SOB, cough, sore thorat, diarrhea, decreased appetite; admitted for COVID-19 infection; tx w/abx, steroids, melatonin; dc home w/O2
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Presented w/ SOB, cough, sore thorat, diarrhea, decreased appetite; admitted for COVID-19 infection; tx w/abx, steroids, melatonin; dc home w/O2
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Localised infection
Clinical narrative: Admitted for rt toe infection; COVID-19 +; tx w/O2 & steroids; weaned of O2 for home dc
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Chills, Pain, Pyrexia
Clinical narrative: Presented to ED w c/o body aches, fever & chills; chest xray showed not acute findings but pt tested COVID-19+; tx w/O2, abx, steroids & zinc; dc'd home on RA
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented to ED w c/o body aches, fever & chills; chest xray showed not acute findings but pt tested COVID-19+; tx w/O2, abx, steroids & zinc; dc'd home on RA
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Hypoxia, Pyrexia
Clinical narrative: Presented w c/o of fever, shortness of breath and was diagnosed with COVID-19.  Patient was noted to be hypoxic and was started on O2, IV steroids, abx, Vit C, zin.  Patient was out of window for remdesivir.  Patient slowly improved and was able to be weaned off to room air.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, COVID-19, COVID-19 pneumonia
Clinical narrative: Presented to ED w/ chief complaint COVID; reports dx w/COVID 1/13 & seen at ER and sent home; admitted for COVID-19 pna & AKI; tx w/abx & Vit C; pt was not hypoxic; pt dc'd home
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19 pneumonia, Pyrexia, Urinary tract infection
Clinical narrative: Presented to ED w/ weakness & fever; admitted for COVID-19 pna, UTI; tx w/ abx, Vit C, Vit D, steroids,
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Deafness unilateral, Dizziness, Hypoaesthesia, Malaise, Rash
Clinical narrative: Was not vaccinated and went to get first shot but instead they gave me the pfizer booster fj8762.  When asked why they gave me the booster they said that was the one I needed.  Felt sick and dizzy after and then proceeded to have a rash that started a few days after.  Hands would go numb and face.  Started having seizures and now I can really do anything. Right side of face is always numb and loss of hearing in right ear.  The worst part is that doctors try to tell you that it's from brain surgery and not the vaccine.  Well it's mathematically impossible for them to give me that answer.  It is morally wrong to do what is going on.  And there is so many other that are dealing with multiple problems and issues that the medical field completely ignores.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure
Clinical narrative: Was not vaccinated and went to get first shot but instead they gave me the pfizer booster fj8762.  When asked why they gave me the booster they said that was the one I needed.  Felt sick and dizzy after and then proceeded to have a rash that started a few days after.  Hands would go numb and face.  Started having seizures and now I can really do anything. Right side of face is always numb and loss of hearing in right ear.  The worst part is that doctors try to tell you that it's from brain surgery and not the vaccine.  Well it's mathematically impossible for them to give me that answer.  It is morally wrong to do what is going on.  And there is so many other that are dealing with multiple problems and issues that the medical field completely ignores.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXEMIA
Age: 83.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bell's palsy
Clinical narrative: RIGHT BELLS PALSY
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Hypoxia, Symptom recurrence
Clinical narrative: HYPOTENSION HYPOXIA 2/16/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Extrasystoles
Clinical narrative: July 6, 2023 annual physical revealed possibly trigeminy. EKG on same date confirmed this diagnosis. Scheduled for echocardiogram for additional information. No prior symptons or signs of this condition.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Haematuria, Hypotension
Clinical narrative: HYPOTENSION 3/23/2023 HEMATURIA
Age: 44.0
Sex: M
Vaccine: HPV9
Symptoms: Impaired work ability, Injection site hypoaesthesia, Injection site pain, Joint noise, Sleep disorder
Clinical narrative: Per client, he was vaccinated with HPV in 3/2023. Following vaccination, he states that he experienced extreme pain in his right shoulder/upper arm. He delayed calling our office because he stated he thought it would go away. Since then, his pain has increased, and he feels a burning and numb sensation in the right shoulder extending down to his elbow, which he rates at a 10/10. He describes it as constant in nature, and it is worsened if he sleeps on his right side. He has attempted to take ibuprofen or Aleve, but states that the pain is still barely tolerable. He feels a pop in his right shoulder when he moves arm. The pain is making it difficult for him at work (hairdresser) as the arm is his dominant side, and it makes it difficult to sleep.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Pulmonary embolism, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM 2/17/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension, Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA HYPOTENSION
Age: 80.0
Sex: F
Vaccine: UNK
Symptoms: Axillary pain, Injection site erythema, Injection site pain, Injection site rash, Rash erythematous
Clinical narrative: (I believe the shot was not given in the usual place in my upper arm; it was closer to  front  of  arm/shoulder than usual.)    By nightfall I experienced pain under my arm, in the armpit, as if there were a painful lump there, although there was no palpable lump. That pain continued to increase during the day. This morning, two days later, the pain under the arm was slightly diminished, but I noticed a 2-3" red rash (not itchy) on that same arm half way between where the shot had been given and my elbow. It was extremely painful to the touch.
Age: 56.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given the incorrect vaccine and vaccine dosage. Patient was administered Pfizer 5-11years undiluted, in the right deltoid. Patient PCP notified, patient was observed for 30 minutes, in addition, the patient was observed for one (1) hour in the waiting area. . The patient did not have any complaints at this time. The paitient PCP observed and spoke with the patient  and told her she was given Pfizer pediactric dose insted of Moderna and reccommended that she wait at the clinic until we obtain additonal information from Pfizer. Pfizer medical was called  and the reccomendation was: Do not repeat the COVID Vaccine.  Patient was given information. Patient left with no negative reactions at that time.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Congenital neuropathy, Symptom recurrence
Clinical narrative: HEREDITARY PERIPHERAL NEUROPATHY 2/19/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY HYPOTENSION
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute kidney injury, COVID-19, Dehydration, Hypophagia, Orthostatic hypotension
Clinical narrative: Patient admitted to hospital with COVID detected PCR. Provider discharge note "Patient is a 90 YO F with history of HTN, HLD, anxiety/depression, who presented with symptoms of orthostasis in setting of poor PO intake and viral syndrome. She was found to have COVID-19 infection and AKI due to dehydration. She was treated with IV fluids and supportive care. Symptoms and AKI resolved overnight and patient reported she felt back to her baseline. Sh was able to eat and drink a regular diet prior to discharge. Will continue holding indapamide and lisinopril on discharge and recommend PCP follow-up in 1 week for repeat BP check and labs. Consider resumption of one or both HTN medications at that time. "
Age: 89.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: SARS-CoV-2 test positive, Viral infection
Clinical narrative: Patient admitted to hospital with COVID detected PCR. Provider discharge note "Patient is a 90 YO F with history of HTN, HLD, anxiety/depression, who presented with symptoms of orthostasis in setting of poor PO intake and viral syndrome. She was found to have COVID-19 infection and AKI due to dehydration. She was treated with IV fluids and supportive care. Symptoms and AKI resolved overnight and patient reported she felt back to her baseline. Sh was able to eat and drink a regular diet prior to discharge. Will continue holding indapamide and lisinopril on discharge and recommend PCP follow-up in 1 week for repeat BP check and labs. Consider resumption of one or both HTN medications at that time. "
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Obstructive sleep apnoea syndrome, Respiratory failure
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA 4/13/2023 ACUTE HYPERCAPNIC RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/20/2023 ACUTE HYPERCAPNIC RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE 4/13/2023 ACUTE HYPERCAPNIC RESPIRATORY FAILURE
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Abdominal distension, COVID-19, Dysuria, SARS-CoV-2 test positive
Clinical narrative: Patient with history of COVID-19 vaccination hospitalized with COVID-19 detected PCR. Provider discharge note "81 YO male presented to ED with 2 days of increasing abdominal distention.  Last bowel movement 3 days ago.  Denies abdominal pain or vomiting.  No fever/chills, though notes burning with urination for the last few days.  Last took Xarelto last night. (HPI per Dr)"
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 0.5
Sex: M
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Diarrhoea, Gastrointestinal disorder, Intestinal operation, Intussusception
Clinical narrative: Pt began with GI sx of loose stools on 6/14/23 and was diagnosed with intussusception on 6/19/23. He underwent surgical correction on 6/20/23.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Neuropathy peripheral
Clinical narrative: NEUROPATHY 3/29/2023 ACUTE LOW BACK PAIN < 1 MONTH
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Heart rate increased, Joint swelling, Myalgia, Palpitations
Clinical narrative: (1) Muscle aches for 6 months after booster (2) Joint pain and swelling for 1 year after booster (3) Intermittent rapid heart rate or palpitations for 18 months after booster
Age: 0.75
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: no known adverse events
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Asthenia, Dizziness, Gait disturbance, Insomnia
Clinical narrative: dizziness, weakness, heart palpitations, anxiety, sleeplessness, feelings of nearly passing out wile standing or walking, could not lay on stomach or side du to heart palpitations, could not walk around block for 3 month, all symptoms disappeared by three month.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: dizziness, weakness, heart palpitations, anxiety, sleeplessness, feelings of nearly passing out wile standing or walking, could not lay on stomach or side du to heart palpitations, could not walk around block for 3 month, all symptoms disappeared by three month.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bell's palsy, Facial paresis
Clinical narrative: RIGHT BELLS PALSY LEFT FACIAL MUSCLE WEAKNESS
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI 1/12/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 1.67
Sex: F
Vaccine: DTAPIPVHIB, HEPA, PNC13
Symptoms: Rash
Clinical narrative: ON 07/19/23 @ 1050AM RASH STARTED TO SPREAD AROUND CLIENT'S TORSO AND DOWN ARMS. MOM ADMINISTERED BENADRYL AT 1110. CLIENT IS EATING, DRINKING AND PLAYING AS NORMAL. MOM GIVIEN EDUCATION ON WHAT REACTIONS TO LOOK FOR IF IMPROVEMENT DOES NOT OCCUR WITH THE BENADRYL.
Age: 22.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest discomfort, Chest pain, Fatigue
Clinical narrative: 1 day after immunziation w bivalent Moderna, chest pain/tightness L side (ipsilateral side of vaccination), squeezing tightness for 2 days. No fever or chills, Resolved after 2 days. Tired as well for 2 days.
Age: 0.58
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: No known events
Age: 86.0
Sex: F
Vaccine: COVID19-2
Symptoms: Coagulopathy
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE
Age: 1.08
Sex: M
Vaccine: HEPA
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: No adverse reaction at the site of the Hepatitis A vaccine.  There is swelling and erythema at the site of the Varicella in right leg and MMR in left leg - local reaction appeared within 5-10 minutes of receiving vaccines. Given Benadryl in the office.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Dyspnoea, Hypoxia, Respiratory failure
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/7/2023 SHORTNESS OF BREATH J96.02 ACUTE HYPERCAPNIC RESPIRATORY FAILURE 4/7/2023 SHORTNESS OF BREATH R09.02 HYPOXIA 4/7/2023 SHORTNESS OF BREATH
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Lung neoplasm malignant
Clinical narrative: I95.9 HYPOTENSION 4/4/2023 LUNG CANCER, RIGHT UPPER LOBE
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Coagulopathy, Neuropathy peripheral
Clinical narrative: COAGULOPATHY, UNSPECIFIED TYPE PERIPHERAL NEUROPATHY
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abnormal behaviour, Asphyxia, Autopsy, Chest pain, Death
Clinical narrative: Swollen lips, and struggling to breath. It reduced after approximately 30 minutes. Unusual behavior, also complaining of chest pain and headaches for several weeks. She died in her sleep april 10th 2022
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Headache, Lip swelling
Clinical narrative: Swollen lips, and struggling to breath. It reduced after approximately 30 minutes. Unusual behavior, also complaining of chest pain and headaches for several weeks. She died in her sleep april 10th 2022
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Hypoxia
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Loss of consciousness, Pallor, Pulse abnormal
Clinical narrative: Patient passed out in lobby of clinic.  Front desk staff called RN to lobby.  Patient's face and lips pale.  Patient was able to stand and was assisted to a chair to sit.  Pulse weak upon palpation. Vitals obtained.  Patient brought back to patient room to lay down with feet elevated, Provider notified and evaluated patient.  Patient laying down for approximately 5 minutes, then assisted to sitting.  Patient was provided and drank 8oz water while sitting.  After approximately 10 minutes of sitting patient's vitals were obtained a second time. Patient assisted to stand and was observed for approximately 2 more minutes.  Patient reported feeling ok, no lightheadedness, weakness, dizziness, tingling in extremities, etc.  Patient allowed to leave clinic.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Bell's palsy, Facial paralysis
Clinical narrative: G51.0 LEFT FACIAL PALSY 3/1/2023 BELLS PALSY
Age: 85.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chronic respiratory failure, Respiratory failure, Symptom recurrence
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/17/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Benign prostatic hyperplasia, Cerebrovascular accident
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 3/31/2023 HX OF ACUTE KIDNEY INJURY ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 3/31/2023 BPH (BENIGN PROSTATIC HYPERPLASIA)
Age: 3.0
Sex: M
Vaccine: TDAP
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Basal ganglia stroke, Coronary artery disease
Clinical narrative: ACUTE STROKE OF BASAL GANGLIA, UNSPECIFIED TYPE AND ARTERY 4/11/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE RESPIRATORY FAILURE 4/11/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 86.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 2/25/2023  &  2/12/2023   --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Condition aggravated, Hypoxia
Clinical narrative: R09.02 HYPOXIA 4/25/2023 CHF EXACERBATION, UNSPECIFIED
Age: 20.0
Sex: F
Vaccine: MENB
Symptoms: Cold sweat, Dizziness, Feeling abnormal, Nausea, Pallor
Clinical narrative: Approximately 8 minutes after patient received vaccine 248 PM she said that she just did not feel good that she was light headed and nauseas. States that when she got to lobby to finish waiting her 15 minutes she went to bathroom to vomit. When nurse got to her in bathroom she was pale, clammy but never loss conciseness. Patient stated that she has done that in past with giving blood but not immunizations. Patient was taken back to exam room and assisted to lie down and given water to drink and given a fan to cool down. BP was taken at 3:00 PM and it was within normal limits at  114/76. Patient  was allowed to cool off and drink water and she also got a piece of candy in case she was having a drop in her blood sugar. After another 15 minutes she stated she felt much better and more like herself and her BP was taken again at 3:15 PM and it was still stable 116/74. Patient  walked out of the clinic in stable condition with her grandmother at her side. No other reactions noted. Patient never had LOC.